Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Large Cap Equity Strategy” ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $482.4, with a high estimate of $567.00 and a low estimate of $420.00. This current average ...

In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1% at $455.45. This change was narrower than the S&P 500's daily loss of 1.13%. Elsewhere, the Dow lost 1.79%, while the tech-heavy ...

RBC Capital’s Brian Abrahams just told Vertex shareholders to hold their horses—literally. Despite Vertex stock closing at ...

The Vera C. Rubin Observatory will share its first highly-detailed images of the sky on Monday. Find details about how to see them here.

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.45% to $448.40 Wednesday, on what proved to be an all-around rough trading ...

This was the stock's third consecutive day of losses.

CCM Investment Advisers gave Vertex Pharmaceuticals a vitamin shot by upping its stake 24.1% in Q1. They purchased an ...

President Trump and Chinese leader Xi Jinping spoke on Thursday, with tariff and trade talks set to resume next week. Trump said Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick ...